BioLife Solutions Inc reports results for the quarter ended in December - Earnings Summary

BioLife Solutions

28/02/2022 22:58

* BioLife Solutions Inc  BLFS.OQ  reported a quarterly
adjusted
loss of 37 cents​​ per share for the quarter ended in December.
The mean expectation of nine analysts for the quarter was for a
loss of 17 cents per share.
    * Revenue rose 153.3% to $37.30 million from a year ago; 
analysts
expected $35.81 million. 
    * BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 37 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * BioLife Solutions Inc shares had fallen by 36.2% this
quarter.
    * The company reported a quarterly loss of $15.22 million.
    * Wall Street's median 12-month price target for BioLife
Solutions
Inc is $64.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 28 at 10:57 p.m.
 ​All figures in US dollars unless otherwise stated